Cargando…

Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial

BACKGROUND: Urothelial carcinomas of the upper urinary tract (UTUCs) are rare, with poorer stage-for-stage prognosis than urothelial carcinomas of the urinary bladder. No international consensus exists on the benefit of adjuvant chemotherapy for patients with UTUCs after nephroureterectomy with cura...

Descripción completa

Detalles Bibliográficos
Autores principales:	Birtle, Alison, Johnson, Mark, Chester, John, Jones, Robert, Dolling, David, Bryan, Richard T, Harris, Christopher, Winterbottom, Andrew, Blacker, Anthony, Catto, James W F, Chakraborti, Prabir, Donovan, Jenny L, Elliott, Paul Anthony, French, Ann, Jagdev, Satinder, Jenkins, Benjamin, Keeley, Francis Xavier, Kockelbergh, Roger, Powles, Thomas, Wagstaff, John, Wilson, Caroline, Todd, Rachel, Lewis, Rebecca, Hall, Emma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181180/ https://www.ncbi.nlm.nih.gov/pubmed/32145825 http://dx.doi.org/10.1016/S0140-6736(20)30415-3

Ejemplares similares

POUT trial: Perioperative chemotherapy in upper tract urothelial carcinoma – A standard of care?
por: Ranjan, Satish Kumar
Publicado: (2020)

Pouting
Publicado: (1859)

Pouting
Publicado: (1880)

Pouting
Publicado: (1878)

Localization of ictal pouting in frontal lobe epilepsy: A case report
por: Koc, Guray, et al.
Publicado: (2017)

Focal seizures associated with the chapeau de gendarme sign or ictal pouting of insular origin
por: Wiwchar, Logan D., et al.
Publicado: (2019)

Creating Three-Dimensional Templates of Smiling and Pouting Faces for Different Sex- and Age Groups
por: Schutte, Hilde, et al.
Publicado: (2022)

Smelling Peppers and Pout Submitted to Convective Drying: Mathematical Modeling, Thermodynamic Properties and Proximal Composition
por: Moura, Rodrigo Leite, et al.
Publicado: (2023)

ATLANTIS: a randomised multi-arm phase II biomarker-directed umbrella screening trial of maintenance targeted therapy after chemotherapy in patients with advanced or metastatic urothelial cancer
por: Fulton, Ben, et al.
Publicado: (2020)

In silico structural and functional modelling of Antifreeze protein (AFP) sequences of Ocean pout (Zoarces americanus, Bloch & Schneider 1801)
por: Bhattacharya, Manojit, et al.
Publicado: (2018)

A netting-based alternative to rigid sorting grids in the small-meshed Norway pout (Trisopterus esmarkii) trawl fishery
por: Eigaard, Ole R., et al.
Publicado: (2021)

Huffmanela lusitana sp. n. (Nematoda: Trichosomoididae) infecting pouting, Trisopterus luscus (Teleostei: Gadidae) off the Atlantic coast of Portugal
por: Ramos, Paula, et al.
Publicado: (2019)

A Randomized, Double-Blind, Biomarker-Selected, Phase II Clinical Trial of Maintenance Poly ADP-Ribose Polymerase Inhibition With Rucaparib Following Chemotherapy for Metastatic Urothelial Carcinoma
por: Crabb, Simon J., et al.
Publicado: (2023)

Key issues in recruitment to randomised controlled trials with very different interventions: a qualitative investigation of recruitment to the SPARE trial (CRUK/07/011)
por: Paramasivan, Sangeetha, et al.
Publicado: (2011)

Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial
por: van der Heijden, Michiel S., et al.
Publicado: (2022)

Clinical Trials Corner
por: Powles, Thomas
Publicado: (2017)

Clinical Guidance for the Management of Patients with Urothelial Cancers During the COVID-19 Pandemic – Rapid Review
por: Patel, K., et al.
Publicado: (2020)

Feasibility Study on Using Dynamic Contrast Enhanced MRI to Assess the Effect of Tyrosine Kinase Inhibitor Therapy within the STAR Trial of Metastatic Renal Cell Cancer
por: Zhong, Jim, et al.
Publicado: (2021)

Current Treatment and Outcomes Benchmark for Locally Advanced or Metastatic Urothelial Cancer From a Large UK-Based Single Centre
por: Cheeseman, Sue, et al.
Publicado: (2020)

Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID)
por: Crabb, Simon J., et al.
Publicado: (2021)

The implementation and utility of patient screening logs in a multicentre randomised controlled oncology trial
por: Lewis, Rebecca, et al.
Publicado: (2020)

Microcystic Variant of Urothelial Carcinoma
por: Venyo, Anthony Kodzo-Grey
Publicado: (2013)

Nested Variant of Urothelial Carcinoma
por: Venyo, Anthony Kodzo-Grey
Publicado: (2014)

Human Papillomavirus in Urothelial Carcinoma of Bladder: An Indian study
por: Mete, Uttam K, et al.
Publicado: (2018)

Specificity of the Metallothionein-1 Response by Cadmium-Exposed Normal Human Urothelial Cells
por: McNeill, Rhiannon V., et al.
Publicado: (2019)

Conveying Equipoise during Recruitment for Clinical Trials: Qualitative Synthesis of Clinicians’ Practices across Six Randomised Controlled Trials
por: Rooshenas, Leila, et al.
Publicado: (2016)

Exploring Novel Endpoints for Clinical Trials in Kidney Disease: Challenges and Opportunities
por: Roy-Chaudhury, Prabir
Publicado: (2017)

Cavitary Pulmonary Nodules in an Immunocompromised Patient With Urothelial Carcinoma of the Bladder
por: Morales, Ayana, et al.
Publicado: (2018)

The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancer
por: Noble, Sian M., et al.
Publicado: (2020)

Integrated Epigenome Profiling of Repressive Histone Modifications, DNA Methylation and Gene Expression in Normal and Malignant Urothelial Cells
por: Dudziec, Ewa, et al.
Publicado: (2012)

Exposure‐response relationship of ramucirumab in RANGE, a randomized phase III trial in advanced urothelial carcinoma refractory to platinum therapy
por: de Wit, Ronald, et al.
Publicado: (2022)

Phase II trial of palbociclib in patients with metastatic urothelial cancer after failure of first-line chemotherapy
por: Rose, Tracy L., et al.
Publicado: (2018)

Strategies adopted by men to deal with uncertainty and anxiety when following an active surveillance/monitoring protocol for localised prostate cancer and implications for care: a longitudinal qualitative study embedded within the ProtecT trial
por: Wade, Julia, et al.
Publicado: (2020)

Mortality Among Men with Advanced Prostate Cancer Excluded from the ProtecT Trial
por: Johnston, Thomas J., et al.
Publicado: (2017)

Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up
por: Powles, Thomas, et al.
Publicado: (2023)

Urothelial toxicity of esketamine in the treatment of depression
por: Findeis, Hannelore, et al.
Publicado: (2020)

Surrogate Endpoints as Predictors of Overall Survival in Metastatic Urothelial Cancer: A Trial-level Analysis
por: Ghali, Fady, et al.
Publicado: (2022)

SUCCINCT: An Open-label, Single-arm, Non-randomised, Phase 2 Trial of Gemcitabine and Cisplatin Chemotherapy in Combination with Sunitinib as First-line Treatment for Patients with Advanced Urothelial Carcinoma
por: Geldart, Thomas, et al.
Publicado: (2015)

The expression of Beta Human Chorionic Gonadotrophin (β-HCG) in human urothelial carcinoma
por: Venyo, Anthony Kodzo-Grey, et al.
Publicado: (2010)

First Evidence of Activity of Enfortumab Vedotin on Brain Metastases in Urothelial Cancer Patients
por: Vulsteke, Christof, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b4762m4fsfsq12dh86gbbb3330